2023 - Research.com Medicine in United Kingdom Leader Award
The scientist’s investigation covers issues in Internal medicine, Cardiology, Cardiomyopathy, Hypertrophic cardiomyopathy and Sudden death. Internal medicine is a component of his Heart disease, Heart failure, Dilated cardiomyopathy, Arrhythmogenic right ventricular dysplasia and Right ventricular cardiomyopathy studies. William J. McKenna has included themes like Transplantation and Risk factor in his Heart failure study.
His work carried out in the field of Cardiomyopathy brings together such families of science as Ejection fraction, Myocarditis, Pathology, Myocardial infarction and Myocyte. His Hypertrophic cardiomyopathy research incorporates elements of Mutation, Muscle hypertrophy, Left ventricular hypertrophy and Atrial fibrillation. He works mostly in the field of Sudden death, limiting it down to topics relating to QRS complex and, in certain cases, PR interval.
His primary scientific interests are in Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Cardiomyopathy and Sudden death. Heart failure, Heart disease, Sudden cardiac death, Right ventricular cardiomyopathy and Dilated cardiomyopathy are among the areas of Internal medicine where the researcher is concentrating his efforts. His studies deal with areas such as Autoantibody and Myocarditis as well as Dilated cardiomyopathy.
His work on Ventricular tachycardia, Electrocardiography and Arrhythmogenic right ventricular dysplasia is typically connected to In patient as part of general Cardiology study, connecting several disciplines of science. His work deals with themes such as Genetics, Muscle hypertrophy, Endocrinology, Left ventricular hypertrophy and Disease, which intersect with Hypertrophic cardiomyopathy. His study in Cardiomyopathy is interdisciplinary in nature, drawing from both Penetrance, Gene mutation and Pathology.
His primary areas of investigation include Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Cardiomyopathy and Sudden cardiac death. Internal medicine and Pathology are commonly linked in his work. William J. McKenna has included themes like Magnetic resonance imaging and Gene mutation in his Cardiology study.
His Hypertrophic cardiomyopathy study combines topics in areas such as Left ventricular hypertrophy, Implantable cardioverter-defibrillator, Mitral valve, Atrial fibrillation and Muscle hypertrophy. In his research, Penetrance and Genetic testing is intimately related to Disease, which falls under the overarching field of Cardiomyopathy. William J. McKenna has researched Sudden cardiac death in several fields, including Asymptomatic, Retrospective cohort study and Cohort.
William J. McKenna mainly focuses on Internal medicine, Cardiology, Cardiomyopathy, Hypertrophic cardiomyopathy and Sudden cardiac death. The various areas that he examines in his Internal medicine study include Magnetic resonance imaging and Gene mutation. His Cardiomyopathy research incorporates themes from Prospective cohort study and Dilated cardiomyopathy.
His biological study spans a wide range of topics, including Left ventricular hypertrophy, Sudden death, Implantable cardioverter-defibrillator, Retrospective cohort study and Atrial fibrillation. The Sudden death study combines topics in areas such as Genetics and TNNT2. His Sudden cardiac death research integrates issues from Fibrosis, Myocardial fibrosis, Predictive value of tests, Cause of death and Sudden cardiac arrest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M Elliott;Aris Anastasakis.
European Heart Journal (2014)
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
P Richardson;W McKenna;M Bristow;B Maisch.
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Proposed Modification of the Task Force Criteria
Frank I. Marcus;William J. McKenna;Duane Sherrill;Cristina Basso.
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Perry Elliott;Bert Andersson;Eloisa Arbustini;Zofia Bilinska.
European Heart Journal (2007)
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Alida L. P. Caforio;Sabine Pankuweit;Eloisa Arbustini;Cristina Basso.
European Heart Journal (2013)
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Michael J. Ackerman;Silvia G. Priori;Stephan Willems;Charles Berul.
Heart Rhythm (2011)
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
Anja A.T. Geisterfer-Lowrance;Susan Kass;Gary Tanigawa;Hans-Peter Vosberg.
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
Domenico Corrado;Antonio Pelliccia;Hans Halvor Bjørnstad;Luc Vanhees.
European Heart Journal (2005)
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study
Cecilia Linde;Christophe Leclercq;Steve Rex;Stephane Garrigue.
Journal of the American College of Cardiology (2002)
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
Ludwig Thierfelder;Ludwig Thierfelder;Hugh Watkins;Hugh Watkins;Calum MacRae;Calum MacRae;Roger Lamas.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: